Legal Representation
Attorney
Martin J. Beran
USPTO Deadlines
Next Deadline
140 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2019-11-26)
Due Date
November 26, 2025
Grace Period Ends
May 26, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
24 eventsDate | Code | Type | Description |
---|---|---|---|
Nov 26, 2024 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
Apr 3, 2020 | FINV | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
Mar 14, 2020 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
Mar 14, 2020 | FIMP | P | FINAL DISPOSITION PROCESSED |
Feb 26, 2020 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Nov 26, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Sep 10, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Sep 10, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION |
Aug 21, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Aug 3, 2019 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Aug 3, 2019 | ALIE | A | ASSIGNED TO LIE |
Jul 25, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jul 19, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jul 19, 2019 | RFNT | P | REFUSAL PROCESSED BY IB |
Jul 18, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jul 18, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Jul 2, 2019 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Jul 2, 2019 | RFRR | P | REFUSAL PROCESSED BY MPU |
Jun 18, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Jun 18, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
Jun 17, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
Jun 12, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
Jun 12, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Jun 6, 2019 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 042
Medical and scientific research in the field of immunology, oncology and immuno-oncology; providing medical and scientific research information in the field of immunology, oncology and immuno-oncology
Additional Information
Design Mark
The mark consists of stripes forming an arrow pointing left. From left to right, the first two stripes are dark orange, the next three stripes are orange and the last three stripes are light orange.
Color Claim
The color(s) light orange, orange and dark orange is/are claimed as a feature of the mark.
Classification
International Classes
042